l General Information |
Product Name | Tiratricol |
General description | Tiratricol is a thyroid hormone analogue. |
Synonym | 2-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]acetic acid; TRIAC; triiodothyroacetic acid |
Purity | ≥98.5%(HPLC) | CAS Number | 51-24-1 |
Formula | C14H9I3O4 | Molecular Weight | 621.935 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White to off-white Solid |
Solubility(25°C) | DMSO | ≥50mg/ml |
Ethanol | ≥50mg/ml |
Water | Very slightly soluble |
l Biological Information |
Biochem/Physiol
Actions | A metabolite of T3 and T4 thyroid hormones; promoted for hyperlipidemia, localized lipodystrophy, and obesity. Tiratricol has been used in trials studying the treatment of Allan-Herndon-Dudley Syndrome. |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
